A randomized, double-blind, parallel-group study evaluating efficacy and safety of MEGA tablets compared to Kalcipos® tablets in adult Subjects
- Registry ID
- EUCTR2006-002595-17
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Recip AB
- Start date
- 2006-10-25
- Last update
- 2026-08-16
Conditions
Summary
The primary objective of the study is to evaluate the efficacy of MEGA compared to Kalcipos on S-25-OH-D after 12 months treatment in Subjects aged 55-85 years with a S-25-OH-D level within 10 and 70 nmol/L at the time of screening.
Locations
View on source registry